Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

PRESS: Sandoz Enbrel Copycat Next Biosimilar To Get Panel Treatment <i>(Scrip)</i>

PRESS: Sandoz Enbrel Copycat Next Biosimilar To Get Panel Treatment (Scrip)

Related Content

Are AI Inventions Harder to Patent?

FDA Platform Technology Draft Guidance Highlights Utility of Obscure Patent Term Extension Provision

USPTO Issues Further Guidance on AI-Related Patent Eligibility

The Rapid Rise of AI, in Five Charts

The Appeals Review Panel’s In Re Xencor Decision: The USPTO Provides Its Position on Written Description and Means-Plus-Function Claims

USPTO’s New Guidance on AI-Assisted Inventions: The Impact on the Use of AI in the Life Sciences

USPTO Issues New Guidance on Patenting AI-Assisted Inventions

What’s Next for AI? Six Areas to Watch in 2024

ACI's 4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA

The Legal 500 UK 2025 Recognizes 26 Practices and 39 Lawyers Across Goodwin’s UK Platform

Markforged To Be Acquired By Nano Dimension In $115 Million All Cash Transaction

Goodwin Represents the Initial Purchasers and Dealers on Box, Inc.’s $460 Million 1.50% Convertible Senior Notes Offering and Capped Call

Sedona Conference WG9/10 Annual Meeting 2024

Navigating the NDCA'S New Whistleblower Protections in the Context of Trade Secret Misappropriation Claims (Daily Journal)

The National Law Journal Honors Amadou Kilkenny Diaw as a DC Rising Star

The Best Lawyers in America 2025 Recognizes 312 Goodwin Lawyers

Life Sciences

Intellectual Property

Complex Litigation & Dispute Resolution

Hatch-Waxman, Biologics and Biosimilars Litigation

Life Sciences Regulatory & Compliance

Litigation